Papyrus Therapeutics
Pre-clinicalDevelops novel therapeutics targeting protein-protein interactions for oncology and inflammatory diseases.
Founded
2018
Focus
Biologics
About
Develops novel therapeutics targeting protein-protein interactions for oncology and inflammatory diseases.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedOct 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile